The US Supreme Court on Thursday temporarily preserved nationwide telehealth and mail access to the abortion medication mifepristone, blocking a lower court ruling that threatened to reinstate strict in-person dispensing requirements while a major legal fight continues. The unsigned order in Danco Laboratories, LLC v. Louisiana and the consolidated case GenBioPro, Inc. v. Louisiana keeps…